Birch Financial Group’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
Other funds holding NVO
EHC
SRIM
MG
OAM
Birch Financial Group's NVO Position: Q2 2026 in Review
Birch Financial Group sold out of Novo Nordisk (NVO) in Q2 2026, closing a stake of 7,471 shares — an estimated $275K sold.
Birch Financial Group first reported a position in NVO in Q4 2024 and held it in 6 quarters. The position peaked at $1.03M in Q2 2025. 819 funds tracked by Wall St. Rank hold NVO as of Q2 2026.
- Birch Financial Group reported no remaining Novo Nordisk position as of Q2 2026 after selling out during the quarter.
- Birch Financial Group sold 7,471 Novo Nordisk shares in Q2 2026, an estimated $275K.
- Birch Financial Group first reported a position in Novo Nordisk in Q4 2024 and held it in 6 quarters.
- Birch Financial Group's Novo Nordisk position peaked at $1.03M in Q2 2025.
- 819 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.
Based on Birch Financial Group's 13F filing for Q2 2026, filed 15 Jul 2026.